Reversal of multidrug resistance in human colon carcinoma cells
申请人:American Cyanamid Comany
公开号:US20020169111A1
公开(公告)日:2002-11-14
The present invention describes the use of fumitremorgin A, B and C and a series of diketopiperazines of Formula (I) to resensitize multidrug resistant (MDR) cancer cells to the cytotoxic effects of chemotherapeutic drugs.